image
Healthcare - Biotechnology - NASDAQ - US
$ 8.23
-0.963 %
$ 1.72 B
Market Cap
-19.14
P/E
BCRX - COST OF REVENUE

Cost of Revenue BCRX - BioCryst Pharmaceuticals, Inc.

image
4.66 M
LAST VALUE
-19.90%
2 YEAR CAGR
58.16%
5 YEAR CAGR
47.14%
10 YEAR CAGR
8m8m7m7m6m6m5m5m4m4m3m3m2m2m1m1m0020152015201620162017201720182018201920192020202020212021202220222023202320242024